The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / E••••• H•••••

H••••••• G•••• Joins GTCR as Investor in E•••••

Type not statedannouncedannounced Sep 10, 2024Fact
What happened
Platform
not an add-on on record
Control
unknown
Share acquired
unknown
Industry
healthcare / healthcare
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
7 named
Buy side
  • J•••• B••••Deal partnerconfirmed
    "After closely tracking the healthcare interpretation market for multiple years, we are thrilled to partner with GTCR and E•••••, which has established itself as a category leader," said J•••• B••••, Partner at H••••••• G••••.
  • H••••••• G••••, a healthcare-focused private equity firm, today announced a significant investment in E••••• H••••• ("E•••••" or the "Company"), a leading provider of tech-enabled, healthcare-focused language interpretation services.
Advisory side
  • G•••••••• D••••••Legal adviserconfirmed
    H•••••• • K••••• LLP and G•••••••• D•••••• served as legal counsel to H••••••• G••••, K••••••• • E•••• L•• served as legal counsel to GTCR.
  • H•••••• • K•••••Legal adviserconfirmed
    H•••••• • K••••• LLP and G•••••••• D•••••• served as legal counsel to H••••••• G••••, K••••••• • E•••• L•• served as legal counsel to GTCR.
  • K••••••• • E•••• L••Legal adviserconfirmed
    H•••••• • K••••• LLP and G•••••••• D•••••• served as legal counsel to H••••••• G••••, K••••••• • E•••• L•• served as legal counsel to GTCR.
Side not stated
  • M•••••• H••••, CEO of E••••• said, "We have a tremendous amount of respect for H••••••• G•••• and the deep healthcare provider and payor relationships they maintain.
  • H••••••• G••••, a healthcare-focused private equity firm, today announced a significant investment in E••••• H••••• ("E•••••" or the "Company"), a leading provider of tech-enabled, healthcare-focused language interpretation services.
Evidence
H••••••• G••••, a healthcare-focused private equity firm, today announced a significant investment in E••••• H••••• ("E•••••" or the "Company"), a leading provider of tech-enabled, healthcare-focused language interpretation services.
H••••••• G•••• Joins GTCR as Investor in E••••• | Private Equity Intelligence | DFX